ST14 Antikörper (AA 298-400)
-
- Target Alle ST14 Antikörper anzeigen
- ST14 (Suppression of Tumorigenicity 14 (Colon Carcinoma) (ST14))
-
Bindungsspezifität
- AA 298-400
-
Reaktivität
- Human
-
Wirt
- Maus
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser ST14 Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), ELISA
- Verwendungszweck
- Mouse polyclonal antibody raised against a partial recombinant ST14.
- Sequenz
- PPSYNLTFHS SQNVLLITLI TNTERRHPGF EATFFQLPRM SSCGGRLRKA QGTFNSPYYP GHYPPNIDCT WNIEVPNNQH VKVRFKFFYL LEPGVPAGTC PKD
- Kreuzreaktivität
- Human
- Produktmerkmale
- Antibody Reactive Against Recombinant Protein.
- Immunogen
- ST14 (NP_068813, 298 a.a. ~ 400 a.a) partial recombinant protein with GST tag.
- Top Product
- Discover our top product ST14 Primärantikörper
-
anti-Suppression of Tumorigenicity 14 (Colon Carcinoma) (ST14) (AA 11-100) antibody
ST14 Reaktivität: Human WB, ELISA, IHC (p), IF (cc), IF (p), IHC (fro) Wirt: Kaninchen Polyclonal unconjugated
anti-Suppression of Tumorigenicity 14 (Colon Carcinoma) (ST14) (AA 826-855), (C-Term) antibodyST14 Reaktivität: Human, Maus WB, IHC (p) Wirt: Kaninchen Polyclonal RB2080 unconjugated
anti-Suppression of Tumorigenicity 14 (Colon Carcinoma) (ST14) (Internal Region) antibodyST14 Reaktivität: Human, Maus WB, ELISA, IHC, IF, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-Suppression of Tumorigenicity 14 (Colon Carcinoma) (ST14) antibodyST14 Reaktivität: Human, Maus, Ratte WB, IHC Wirt: Kaninchen Polyclonal unconjugated
anti-Suppression of Tumorigenicity 14 (Colon Carcinoma) (ST14) (C-Term) antibodyST14 Reaktivität: Human, Maus, Ratte, Rind (Kuh), Meerschweinchen, Pferd, Schwein, Kaninchen, Hund WB, IHC Wirt: Kaninchen Polyclonal unconjugated
anti-Suppression of Tumorigenicity 14 (Colon Carcinoma) (ST14) (N-Term) antibodyST14 Reaktivität: Human WB, IF, IHC (p), EIA Wirt: Kaninchen Polyclonal unconjugated
anti-Suppression of Tumorigenicity 14 (Colon Carcinoma) (ST14) antibodyST14 Reaktivität: Human, Maus ELISA, IHC Wirt: Kaninchen Polyclonal unconjugated
anti-Suppression of Tumorigenicity 14 (Colon Carcinoma) (ST14) (AA 298-400) antibodyST14 Reaktivität: Human ELISA Wirt: Maus Monoclonal 2F4 unconjugated
anti-Suppression of Tumorigenicity 14 (Colon Carcinoma) (ST14) (AA 10-59) antibodyST14 Reaktivität: Human WB, ELISA, IHC, IF, IHC (p) Wirt: Kaninchen Polyclonal unconjugated
anti-Suppression of Tumorigenicity 14 (Colon Carcinoma) (ST14) (N-Term) antibodyST14 Reaktivität: Human WB, ELISA, IF Wirt: Kaninchen Polyclonal unconjugated
-
- Applikationshinweise
- Optimal working dilution should be determined by the investigator.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Buffer
- 50 % glycerol
- Handhabung
- Aliquot to avoid repeated freezing and thawing.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Store at -20°C or lower. Aliquot to avoid repeated freezing and thawing.
-
- Target
- ST14 (Suppression of Tumorigenicity 14 (Colon Carcinoma) (ST14))
- Andere Bezeichnung
- ST14 (ST14 Produkte)
- Hintergrund
-
Full Gene Name: suppression of tumorigenicity 14 (colon carcinoma)
Synonyms: HAI,MT-SP1,MTSP-1,MTSP1,PRSS14,SNC19,TADG-15 - Gen-ID
- 6768
- NCBI Accession
- NM_021978
-
